Patent US5861426A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5861426A Expired / Lapsed US ⏱️ 0.0 years remaining

Nitro compounds of the formula A-Xi -NO2 and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities

Assignee: Nicox SA
•
Filing: 1995-04-04
•
Granted: 1999-01-19
•
Expires: 2015-04-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract PCT No. PCT/EP95/01233 Sec. 371 Date Mar. 6, 1997 Sec. 102(e) Date Mar. 6, 1997 PCT Filed Apr. 4, 1995 PCT Pub. No. WO95/30641 PCT Pub. Date Nov. 16, 1995New compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities, of the general formula: A-X1-NO2 or their salts, wherein: A is R(COXu)t, wherein t is zero or 1 and u is zero or 1; and X is O, NH or NR1C wherein R1C is C1-C10 alkyl; and R is(Ia) wherein R1 is acetoxoy, preferably n ortho-position with respect to -CO- and R2 is hydrogen; or derivatives of acetylsalylsalicyclic acid; and X1 is -YO- wherein Y is C1-C20 alkylene, C5-C7 cycloalkylene, oxy-alkyl derivatives and oxy-methyl benzyl derivatives.

Inventors

  • 👤 Piero del Soldato
  • 👤 Francesco Sannicolo

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 19:27
CPC Classifications
C; C07; C07D; C07D487/00; C07D487/02; C07D487/04; A; A61; A61P; A61P25/00; A61P25/04; A61P29/00; A61P31/00; A61P31/04; A61P43/00; A61P7/00; A61P7/02; A61P9/00; A61P9/08; A61P9/10; C07C; C07C203/00; C07C203/02; C07C203/04; C07D209/00; C07D209/02; C07D209/04; C07D209/10; C07D209/18; C07D209/26; C07D209/28; C07D333/00; C07D333/02; C07D333/04; C07D333/06; C07D333/24

Claims Analysis

Total Claims: 41
Claim 1
Independent Claim 1109 words
A compound having the formula: A--X.sub.1 --NO.sub.2 or their salts, wherein: A=R(COX u ) t , wherein t=0 or 1; u=0 or 1, X=O, NH, NR 1C , wherein R 1C is a linear or branched alkyl having 1 to 10 C atoms; R is selected from the following groups: group I), wherein t=1 and u=1, and R is: ##STR26## wherein: R 1 is an OCOR 3 group; R 3 is methyl, ethyl or a linear or branched C 3 -C 5 alkyl, or a nonaromatic or aromatic heterocycle with a single ring having 5 or 6 atoms containing one or more heteroatoms independently selected from O, N, and S; R 2 is hydrogen, hydroxy, a halogen, a linear or branched alkyl having 1 to 4 C atoms, a linear or branched alkoxyl having 1 to 4 C atoms, a linear or branched perfluoroalkyl having 1 to 4 C atoms, nitro, amino, mono- or di-(C 1-4 ) alkylamino; or R 1 and R 2 together are a dioxymethylene group, with the proviso that when X=NH, then X 1 is ethylene and R 2 =H; R 1 cannot be OCOR 3 in position 2 when R 3 is methyl; nI is 0 or 1; group II) wherein t=1 and u=1, and R is: ##STR27## wherein: R II5 is H, a linear or branched C 1 -C 3 alkyl; R II6 is H, a linear or branched C 1 -C 3 alkyl; or, when R II5 is H, R II6 is benzyl; R II1 , R II2 and R II3 , independently from one another, are H, a linear or branched C 1 -C 6 alkyl or C 1 -C 6 alkoxy, or Cl, F, Br; R II4 is R II1 or Br; group III), wherein t=1, u=1 and R is: ##STR28## wherein: R 2a and R 3a are H, a linear or branched, substituted or nonsubstituted C 1 -C 12 alkyl, allyl, with the proviso that when one of the two groups is allyl, the other is H; R 1a is chosen from ##STR29## or group IIID, wherein R 1a is: ##STR30## wherein in formula (IV), R III1 is H or SR III3 , wherein R III3 has from 1 to 4 C atoms, linear or branched; R III2 is H or hydroxy; wherein in formula (XXI), R XXio is H, a linear or branched alkyl having from 1 to 6 C atoms, a C 1 -C 6 alkoxycarbonyl bound to a C 1 -C 6 alkyl, a C 1 -C 6 carboxylalkyl, a C 1 -C 6 alkanoyl, unsubstituted or substituted with a halogen, benzyl or halobenzyl, benzoyl or halobenzoyl; R XXi is H, a halogen, hydroxy, CN, a C 1 -C 6 alkyl, a C 1 -C 6 alkoxy, acetyl, benzyloxy, SR XXi2 , wherein R XXi2 is an alkyl C 1 -C 6 ; a perfluoroalkyl having from 1 to 3 C atoms, a C 1 -C 6 carboxyalkyl, NO 2 , amino, sulphamoyl, a dialkyl sulphamoyl with the alkyl having from 1 to 6 C atoms, or a di-fluroalkyl sulphonyl with the alkyl having from 1 to 3 C atoms; R XXi1 is a halogen, CN, a C 1 -C 6 alkyl, a C 1 -C 6 alkoxy, acetyl, acetamide, benzyloxy, SR III3 is as above defined, a perfluoroalkyl having from 1 to 3 C atoms, hydroxy, a carboxyalkyl having from 1 to 6 C atoms, NO 2 , amino, a mono- or di-alkylamino having from 1 to 6 C atoms, sulphamoyl, a di-alkyl sulphamoyl having from 1 to 6 C atoms, or a di-fluoroalkyl sulphamoyl having from 1 to 6 atoms; or R XX1 together with R XXi1 is an alkylene dioxy having from 1 to 6 C atoms; wherein in formula (XXXV), Ar is phenyl, a hydroxyphenyl unsubstituted or substituted with a halogen, an alkanoyl and an alkoxy having from 1 to 6 C atoms, a trialalkyl having from 1 to 6 C atoms, cyclo-pentyl, cylo-hexyl, cyclo-heptyl, heteroaryl, furyl, pyridyl; group IV) wherein t=1, u=1, and R is ##STR31## wherein: R IVd and R IVd1 are at least one H and the other a linear or branched C 1 -C 6 alkyl, or a di-fluoroalkyl with the alkyl having from 1 to 6 C, or R IVd and R IVd1 together form a methylene group; wherein R IV is selected from: ##STR32## wherein in formula (II): R v-ii is a 1-6 C alkyl, a cycloalkyl having from 3 to 7 C atoms, an alkoxymethyl having from 1 to 7 C atoms, a trifluroalkyl having from 1 to 3 C atoms, vinyl, ethinyl, halogen, an alkoxy having from 1 to 6 C atoms, a di-fluoroalkoxy with the alkyl having from 1 to 7 C atoms, an alkoxymethyloxy having from 1 to 7 C atoms, an alkylthiomethyloxy with the alkyl having from 1 to 7 C atoms, an alkyl methylthio with the alkyl having from 1 to 7 C atoms, cyano, di-fluoromethylthio, phenyl or phenylalkyl substituted with the alkyl having from 1 to 8 C atoms; wherein in formula (III): R iv-iii is a linear or branched C 2 -C 5 alkyl, a C 2 and C 3 alkyloxy, allyloxy, phenoxy, phenylthio, a cycloalkyl having from 5 to 7 C atoms; group V), R is: ##STR33## wherein in the radicals of formula (II), R vii is H or a linear or branched alkyl having from 1 to 4 C atoms; R vii-1 is as defined for R vii or a linear or branched alkoxy having from 1 to 4 C atoms; Cl, F, Br; and the position of R vii-1 is o-, m- or p-; X 1 in the formula A--X 1 --NO 2 is a bivalent connecting bridge selected from the following: --YO-- wherein Y is: a linear or branched C 1 -C 20 alkylene, with the proviso that the connection bridge is excluded when R is: a radical of group I) except radicals of formula (Ib) and (Ic); a radical of group II) except radicals of formula (II b ); a radical of group III) except radicals of group (IIID); a radical of group IV); a radical of group V), except radicals of formula (X) and including --(CH 2 ) 4 -- for the compounds of formula (III) and (IV); or a cycloalkylene having from 5 to 7 carbon atoms, excluding this connecting bridge when R is a radical of formula (Ia) of group I; ##STR34## wherein n 3 is 0 or an integer from 1 to 3, ##STR35## wherein nf' is an integer from 1 to 6, ##STR36## wherein R 1f =H, --CH 3 and nf is an integer from 1 to 6.
Claim 2
Dependent Claim 1109 words
A compound having the formula: A--X.sub.1 --NO.sub.2 or their salts, wherein: A=R(COX u ) t , wherein t=0 or 1; u=0 or 1, X=O, NH, NR 1C , wherein R 1C is a linear or branched alkyl having 1 to 10 C atoms; R is selected from the following groups: group I), wherein t=1 and u=1, and R is: ##STR26## wherein: R 1 is an OCOR 3 group; R 3 is methyl, ethyl or a linear or branched C 3 -C 5 alkyl, or a nonaromatic or aromatic heterocycle with a single ring having 5 or 6 atoms containing one or more heteroatoms independently selected from O, N, and S; R 2 is hydrogen, hydroxy, a halogen, a linear or branched alkyl having 1 to 4 C atoms, a linear or branched alkoxyl having 1 to 4 C atoms, a linear or branched perfluoroalkyl having 1 to 4 C atoms, nitro, amino, mono- or di-(C 1-4 ) alkylamino; or R 1 and R 2 together are a dioxymethylene group, with the proviso that when X=NH, then X 1 is ethylene and R 2 =H; R 1 cannot be OCOR 3 in position 2 when R 3 is methyl; nI is 0 or 1; group II) wherein t=1 and u=1, and R is: ##STR27## wherein: R II5 is H, a linear or branched C 1 -C 3 alkyl; R II6 is H, a linear or branched C 1 -C 3 alkyl; or, when R II5 is H, R II6 is benzyl; R II1 , R II2 and R II3 , independently from one another, are H, a linear or branched C 1 -C 6 alkyl or C 1 -C 6 alkoxy, or Cl, F, Br; R II4 is R II1 or Br; group III), wherein t=1, u=1 and R is: ##STR28## wherein: R 2a and R 3a are H, a linear or branched, substituted or nonsubstituted C 1 -C 12 alkyl, allyl, with the proviso that when one of the two groups is allyl, the other is H; R 1a is chosen from ##STR29## or group IIID, wherein R 1a is: ##STR30## wherein in formula (IV), R III1 is H or SR III3 , wherein R III3 has from 1 to 4 C atoms, linear or branched; R III2 is H or hydroxy; wherein in formula (XXI), R XXio is H, a linear or branched alkyl having from 1 to 6 C atoms, a C 1 -C 6 alkoxycarbonyl bound to a C 1 -C 6 alkyl, a C 1 -C 6 carboxylalkyl, a C 1 -C 6 alkanoyl, unsubstituted or substituted with a halogen, benzyl or halobenzyl, benzoyl or halobenzoyl; R XXi is H, a halogen, hydroxy, CN, a C 1 -C 6 alkyl, a C 1 -C 6 alkoxy, acetyl, benzyloxy, SR XXi2 , wherein R XXi2 is an alkyl C 1 -C 6 ; a perfluoroalkyl having from 1 to 3 C atoms, a C 1 -C 6 carboxyalkyl, NO 2 , amino, sulphamoyl, a dialkyl sulphamoyl with the alkyl having from 1 to 6 C atoms, or a di-fluroalkyl sulphonyl with the alkyl having from 1 to 3 C atoms; R XXi1 is a halogen, CN, a C 1 -C 6 alkyl, a C 1 -C 6 alkoxy, acetyl, acetamide, benzyloxy, SR III3 is as above defined, a perfluoroalkyl having from 1 to 3 C atoms, hydroxy, a carboxyalkyl having from 1 to 6 C atoms, NO 2 , amino, a mono- or di-alkylamino having from 1 to 6 C atoms, sulphamoyl, a di-alkyl sulphamoyl having from 1 to 6 C atoms, or a di-fluoroalkyl sulphamoyl having from 1 to 6 atoms; or R XX1 together with R XXi1 is an alkylene dioxy having from 1 to 6 C atoms; wherein in formula (XXXV), Ar is phenyl, a hydroxyphenyl unsubstituted or substituted with a halogen, an alkanoyl and an alkoxy having from 1 to 6 C atoms, a trialalkyl having from 1 to 6 C atoms, cyclo-pentyl, cylo-hexyl, cyclo-heptyl, heteroaryl, furyl, pyridyl; group IV) wherein t=1, u=1, and R is ##STR31## wherein: R IVd and R IVd1 are at least one H and the other a linear or branched C 1 -C 6 alkyl, or a di-fluoroalkyl with the alkyl having from 1 to 6 C, or R IVd and R IVd1 together form a methylene group; wherein R IV is selected from: ##STR32## wherein in formula (II): R v-ii is a 1-6 C alkyl, a cycloalkyl having from 3 to 7 C atoms, an alkoxymethyl having from 1 to 7 C atoms, a trifluroalkyl having from 1 to 3 C atoms, vinyl, ethinyl, halogen, an alkoxy having from 1 to 6 C atoms, a di-fluoroalkoxy with the alkyl having from 1 to 7 C atoms, an alkoxymethyloxy having from 1 to 7 C atoms, an alkylthiomethyloxy with the alkyl having from 1 to 7 C atoms, an alkyl methylthio with the alkyl having from 1 to 7 C atoms, cyano, di-fluoromethylthio, phenyl or phenylalkyl substituted with the alkyl having from 1 to 8 C atoms; wherein in formula (III): R iv-iii is a linear or branched C 2 -C 5 alkyl, a C 2 and C 3 alkyloxy, allyloxy, phenoxy, phenylthio, a cycloalkyl having from 5 to 7 C atoms; group V), R is: ##STR33## wherein in the radicals of formula (II), R vii is H or a linear or branched alkyl having from 1 to 4 C atoms; R vii-1 is as defined for R vii or a linear or branched alkoxy having from 1 to 4 C atoms; Cl, F, Br; and the position of R vii-1 is o-, m- or p-; X 1 in the formula A--X 1 --NO 2 is a bivalent connecting bridge selected from the following: --YO-- wherein Y is: a linear or branched C 1 -C 20 alkylene, with the proviso that the connection bridge is excluded when R is: a radical of group I) except radicals of formula (Ib) and (Ic); a radical of group II) except radicals of formula (II b ); a radical of group III) except radicals of group (IIID); a radical of group IV); a radical of group V), except radicals of formula (X) and including --(CH 2 ) 4 -- for the compounds of formula (III) and (IV); or a cycloalkylene having from 5 to 7 carbon atoms, excluding this connecting bridge when R is a radical of formula (Ia) of group I; ##STR34## wherein n 3 is 0 or an integer from 1 to 3, ##STR35## wherein nf' is an integer from 1 to 6, ##STR36## wherein R 1f =H, --CH 3 and nf is an integer from 1 to 6.
Claim 3
Dependent Claim 109 words
The compound according to claim 1, wherein, in group I): in the radicals of formula (Ia): X is O, R1 is acetoxy, X 1 is (CH 2 --CH 2 --O) 2 , R 2 is hydrogen; in the radicals of formula (Ib): R 3 =CH 3 , nI=O, X is equal to O, X 1 is ethylene; in group II): wherein R II1 , R II2 and R II4 are H, R II3 is chlorine and R II3 is in the ortho position relative to HN; R II5 and R II6 are H; X is equal to O, and X 1 is (CH 2 --CH 2 --O) 2 .
Claim 4
Dependent Claim 19 words
A pharmaceutical composition containing the compound according to claim 1 or 2 in admixture with a pharmaceutically acceptable excipient.
Claim 5
Dependent Claim 109 words
A method for the treatment of septic shock which comprises administration of an effective amount of the compound having the formula: A--X.sub.1 --NO.sub.2 wherein A is as defined by claim 1 or 2 and X 1 is a bivalent connecting bridge chosen from the following: --YO-- wherein Y is: a linear or branched C 1 -C 20 alkylene, an unsubstituted or substituted cycloalkylene having from 5 to 7 carbon atoms; ##STR37## wherein n 2 is 0 or an integer from 1 to 3, ##STR38## wherein nf' is an integer from 1 to 6, ##STR39## wherein R 1f =H, --CH 3 and nf is an integer from 1 to 6.
Claim 6
Dependent Claim 166 words
A method for the treatment of inflammation which comprises administration of an anti-inflammatory amount of a compound having general formula: A--X.sub.1 --NO.sub.2 wherein A is defined by claim 1 or 2 and X 1 is a bivalent connecting bridge chosen from the following: --YO-- where Y is: a linear or branched C 1 -C 20 alkylene, excluding this connecting bridge when R is: a radical of group II) except radicals of formula (II b ); a radical of group III) except radicals of group (IIID) a radical of group IV); a radical of group V), except radicals of formula (X) and including --(CH 2 ) 4 -- for the radicals of formulae (III) and (IV); an unsubstituted or substituted cycloalklene having from 5 to 7 carbon atoms; ##STR40## wherein n 3 is 0 or an integer from 1 to 3, ##STR41## wherein nf' is an integer from 1 to 6, ##STR42## wherein R 1f =H, --CH 3 and nf is an integer from 1 to 6.
Claim 7
Dependent Claim 160 words
A method for anti-thrombotic treatment which comprises administration of an antithrombotic amount of a compound having the formula A--X.sub.1 --NO.sub.2 wherein A is as defined by claim 1 or 2 and X 1 is a bivalent connecting bridge selected from the following: --YO-- where Y is: a linear or branched C 1 -C 20 alkylene, excluding this connecting bridge when R is: a radical of group II) except radicals of formula (II b ); a radical of group III) except radicals of group (IIID) a radical of group IV); a radical group of V), except formula (X) and including --(CH 2 ) 4 -- for the radicals of formulae (iii) and (IV); a cycloalkylene having from 5 to 7 carbon atoms, ##STR43## wherein n 3 is 0 or an integer from 1 to 3, ##STR44## wherein nf' is an integer from 1 to 6, ##STR45## wherein R 1f =H, --CH 3 and nf is an integer from 1 to 6.
Claim 8
Dependent Claim 163 words
A method for analgesic treatment comprising administration of an analgesic amount of a compound of the general formula: A--X.sub.1 --NO.sub.2 wherein A is as defined by claim 1 or 2 and X 1 is a bivalent connecting bridge selected from the following: --YO-- where Y is: a linear or branched C 1 -C 20 alkylene, excluding this connecting bridge when R is: a radical of group II) except radicals of formula (II b ); a radical of group III) except radicals of group (IIID); a radical of group IV); a radical group of V), except formula (X) and including --(CH 2 ) 4 -- for the radicals of formulae (iii) and (IV); an unsubstituted or substituted cycloalkylene having from 5 to 7 carbon atoms; ##STR46## wherein n 3 is 0 or an integer from 1 to 3, ##STR47## wherein nf' is an integer from 1 to 6, ##STR48## wherein R 1f =H, --CH 3 and nf is an integer from 1 to 6.
Claim 9
Dependent Claim 33 words
The compound of claim 1, wherein R is as defined by group III, formula (IV), wherein R III1 and R III2 are H, R 3a is H, R 2a is methyl, and X=O.
Claim 10
Dependent Claim 56 words
The compound of claim 1, wherein R is as defined by group III, formula (XXI), wherein R XXio is H, the connecting bridge is in position 2, R XX1 is H, R XX11 is chlorine and is in the para position relative to nitrogen; R 3a is H, R 2a is methyl, and X is O.
Claim 11
Dependent Claim 31 words
The compound of claim 1, wherein R is as defined by group III, formula (XXXV), wherein Ar is phenyl, R 3a is H, R 2a is methyl, and X is O.
Claim 12
Dependent Claim 26 words
The compound of claim 1, wherein R is as defined by group III, formula (II), wherein R 3a is H, R 2a is methyl, and X=O.
Claim 13
Dependent Claim 22 words
The compound of claim 1, wherein R is as defined by group III, formula (VI), wherein R 2a is CH 3 .
Claim 14
Dependent Claim 27 words
The compound of claim 2, wherein R is as defined by group III, formula (VI), wherein R 2a is H, R 3a =CH 3 , and X=O.
Claim 15
Dependent Claim 23 words
The compound of claim 1, wherein R is as defined by group III, formula (VIII), wherein R 2a =R 3a =H and X=O.
Claim 16
Dependent Claim 25 words
The compound of claim 1, wherein R is as defined by group III, formula (VII), wherein R 3a =X, R 2a =--CH 3 and X=O.
Claim 17
Dependent Claim 23 words
The compound of claim 1, wherein R is as defined by group III, formula (III), wherein R 2a =R 3a =H and X=O.
Claim 18
Dependent Claim 27 words
The compound of claim 1, wherein R is as defined by group III, formula (IX), wherein R 3a is H, R 2a is --CH 3 and X=O.
Claim 19
Dependent Claim 23 words
The compound of claim 1, wherein R is as defined by group III, formula (X), wherein R 2a =R 3a =H and X=O.
Claim 20
Dependent Claim 35 words
The compound of claim 1, wherein R is as defined by group III, and R 1a is defined by group IIID, formula (IIIa), wherein R 2a =H, R 3a =--CH 3 , u=1 and X=O.
Claim 21
Dependent Claim 35 words
The compound of claim 1, wherein R is as defined by group III, and R 1a is defined by group IIID, formula (XXX), wherein R 2a =H, R 3a =CH 3 , u=1 and X=O.
Claim 22
Dependent Claim 35 words
The compound of claim 1, wherein R is as defined by group III, and R 1a is defined by group IIID, formula (XXXI) wherein R 2a =H, R 3a =CH 3 , u=1 and X=O.
Claim 23
Dependent Claim 32 words
The compound of claim 1, wherein R is as defined by group III, and R 1a is defined by group IIID, formula (XXXII) wherein R 2a =R 3a =H, u=1 and X=O.
Claim 24
Dependent Claim 32 words
The compound of claim 1, wherein R is as defined by group III, and R 1a is defined by group IIID, formula (XXXIII) wherein R 2a =R 3a =H, u=1 and X=O.
Claim 25
Dependent Claim 35 words
The compound of claim 1, wherein R is as defined by group III, and R 1a is defined by group IIID, formula (XXXVI) wherein R 2a =H, R 3a =CH 3 , u=1 and X=O.
Claim 26
Dependent Claim 32 words
The compound of claim 1, wherein R is as defined by group III, and R 1a is defined by group IIID, formula (XXXVII) wherein R 2a =R 3a =H, t=1 and X=O.
Claim 27
Dependent Claim 44 words
The compound of claim 1, wherein R is as defined by group IV, formula (II) wherein R iv-ii is CH 3 O, R ivd is H and R ivd1 is --CH3, X=NH or O and X 1 =--(CH 2 --CH 2 --O) 2 .
Claim 28
Dependent Claim 43 words
The compound of claim 1, wherein R is as defined by group IV, formula (X) wherein R IVd is H and R IVd1 is --CH 3 , X=NH or O and X 1 is equal to (CH 2 --CH 2 --O) 2 .
Claim 29
Dependent Claim 46 words
The compound of claim 1, wherein R is as defined by group IV, formal (III), wherein R IV-111 is ##STR49## and R IVd =H, R IVd1 is --CH 3 , X=NH or O and X 1 is equal to (CH 2 --CH 2 --O) 2 .
Claim 30
Dependent Claim 27 words
The compound of claim 1, wherein R is as defined by group V, formula (II), wherein R vii and R vii-1 are H, and A=R and t=0.
Claim 31
Dependent Claim 19 words
The compound of claim 1, wherein R is as defined by group V, formula (V), wherein A=R and t=0.
Claim 32
Dependent Claim 29 words
The compound of claim 1, wherein R is as defined by group V, formula (VII), wherein A is RCO and t=1 and u=0 or A is R and t=0.
Claim 33
Dependent Claim 19 words
The compound of claim 1, wherein R is as defined by group V, formula (IX), wherein A=R and t=0.
Claim 34
Dependent Claim 20 words
The compound of claim 1, wherein R is as defined by group V, formula (IX), wherein A=RCO, t=1 and u=0.
Claim 35
Dependent Claim 26 words
The compound of claim 1, wherein R is as defined by group V, formula (III) wherein A=RCOO, t=1 and u=0 or 1; or A=R and t=0.
Claim 36
Dependent Claim 19 words
The compound of claim 1, wherein R is as defined by group V, formula (III) wherein A=R and t=0.
Claim 37
Dependent Claim 20 words
The compound of claim 1, wherein R is as defined by group V, formula (IV), wherein A=RCOO, t=1, and u=1.
Claim 38
Dependent Claim 17 words
The compound of claim 1, wherein R is as defined by group V, formula (X), wherein t=0.
Claim 39
Dependent Claim 20 words
The compound of claim 1, wherein R is as defined by group V, formula (XI), wherein u=1, X=O; and t=0.
Claim 40
Dependent Claim 25 words
The compound of claim 1, wherein R is as defined by group V, formula (XII), wherein R 2a =R 3a =H, u=1, X=O, and t=0.
Claim 41
Dependent Claim 16 words
The compound of claim 1, wherein R is as defined by group V, formula (XIII) t=0.

References Cited (Backward Citations)

WO1992001668A1 Cited
EP0549797A1 Cited
WO1994004484A1 Cited
WO1994012463A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-01-18 2002-07-20 2003-01-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-01-18 2006-07-20 2007-01-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-01-18 2010-07-20 2011-01-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag